Literature DB >> 26085284

Acute human herpesvirus-6A infection of human mesothelial cells modulates HLA molecules.

Elisabetta Caselli1, Diana Campioni, Francesco Cavazzini, Valentina Gentili, Daria Bortolotti, Antonio Cuneo, Dario Di Luca, Roberta Rizzo.   

Abstract

Human herpesvirus 6A (HHV-6A) causes ubiquitous infections and has been associated with several diseases in immunosuppressed and immune dysregulated individuals. Although considered a lymphotropic virus, HHV-6A has the potential to infect many cell types, inducing important alterations in the infected cell. In our search for additional potential targets for HHV-6A infection, we analyzed the susceptibility of human mesothelial cells to viral infection. HHV-6A infection was performed and analyzed on primary human mesothelial cells isolated from serous cavity fluid, infected in vitro with a cell-free HHV-6A inoculum. The results demonstrated that mesothelial cells are susceptible to in vitro HHV-6A infection, and more importantly, that the virus induces an alteration of HLA expression on the cell surface, inducing HLA class II and HLA-G de novo expression. Since mesothelial cells play a pivotal role in many processes, including inflammation and antigen presentation, we speculate that, in vivo, this virus-induced perturbation might be correlated to alterations in mesothelium functions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26085284     DOI: 10.1007/s00705-015-2490-3

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  8 in total

1.  HHV-6A/6B Infection of NK Cells Modulates the Expression of miRNAs and Transcription Factors Potentially Associated to Impaired NK Activity.

Authors:  Roberta Rizzo; Irene Soffritti; Maria D'Accolti; Daria Bortolotti; Dario Di Luca; Elisabetta Caselli
Journal:  Front Microbiol       Date:  2017-10-31       Impact factor: 5.640

2.  HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis.

Authors:  Antonino Tuttolomondo; Claudia Colomba; Danilo Di Bona; Alessandra Casuccio; Domenico Di Raimondo; Giuseppe Clemente; Valentina Arnao; Rosaria Pecoraro; Paolo Ragonese; Anna Aiello; Giulia Accardi; Rosario Maugeri; Carlo Maida; Irene Simonetta; Vittoriano Della Corte; Domenico Gerardo Iacopino; Calogero Caruso; Antonio Cascio; Antonio Pinto
Journal:  Oncotarget       Date:  2018-04-03

3.  Human Herpesvirus 6A and 6B inhibit in vitro angiogenesis by induction of Human Leukocyte Antigen G.

Authors:  Roberta Rizzo; Maria D'Accolti; Daria Bortolotti; Francesca Caccuri; Arnaldo Caruso; Dario Di Luca; Elisabetta Caselli
Journal:  Sci Rep       Date:  2018-12-06       Impact factor: 4.379

4.  HHV-6A Infection and Systemic Sclerosis: Clues of a Possible Association.

Authors:  Elisabetta Caselli; Irene Soffritti; Maria D'Accolti; Daria Bortolotti; Roberta Rizzo; Gianluca Sighinolfi; Dilia Giuggioli; Clodoveo Ferri
Journal:  Microorganisms       Date:  2019-12-24

Review 5.  The U94 Gene of Human Herpesvirus 6: A Narrative Review of Its Role and Potential Functions.

Authors:  Elisabetta Caselli; Maria D'Accolti; Francesca Caccuri; Irene Soffritti; Valentina Gentili; Daria Bortolotti; Antonella Rotola; Enzo Cassai; Simona Fiorentini; Alberto Zani; Arnaldo Caruso; Roberta Rizzo; Dario Di Luca
Journal:  Cells       Date:  2020-12-04       Impact factor: 6.600

Review 6.  Role of HLA-G in Viral Infections.

Authors:  Simon Jasinski-Bergner; Dominik Schmiedel; Ofer Mandelboim; Barbara Seliger
Journal:  Front Immunol       Date:  2022-02-14       Impact factor: 7.561

Review 7.  The Interplay between Natural Killer Cells and Human Herpesvirus-6.

Authors:  Eva Eliassen; Dario Di Luca; Roberta Rizzo; Isabel Barao
Journal:  Viruses       Date:  2017-12-01       Impact factor: 5.048

8.  The P2X7 Receptor 489C>T Gain of Function Polymorphism Favors HHV-6A Infection and Associates With Female Idiopathic Infertility.

Authors:  Anna Pegoraro; Daria Bortolotti; Roberto Marci; Elisabetta Caselli; Simonetta Falzoni; Elena De Marchi; Francesco Di Virgilio; Roberta Rizzo; Elena Adinolfi
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.